Stay updated on Ixazomib Role in ASCT in Relapsed Myeloma - Clinical Trial

Sign up to get notified when there's something new on the Ixazomib Role in ASCT in Relapsed Myeloma - Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ixazomib Role in ASCT in Relapsed Myeloma - Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    New quick-access links 'Check who can join' and 'Find Contact Information' appear on the record history page to facilitate access to eligibility details and contact information for the study. The revision history now shows version 3.6.0 and removes the previous 3.5.5 entry, indicating an updated record.
    Difference
    0.6%
    Check dated 2026-06-12T23:57:55.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A new revision entry 'Revision: v3.5.5' is added to the record history. The previous 'Revision: v3.5.4' entry is removed, updating the displayed version history.
    Difference
    0.1%
    Check dated 2026-06-05T22:18:52.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    A new revision entry v3.5.4 was added to the history. The previous entry v3.5.3 was removed, updating the page’s revision trail.
    Difference
    0.1%
    Check dated 2026-05-15T14:26:25.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    Updates the ClinicalTrials.gov page revision identifier from v3.5.2 to v3.5.3, reflecting a site/version change rather than a modification to the underlying trial record.
    Difference
    0.1%
    Check dated 2026-04-24T06:20:17.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Revision: v3.5.2 was added and Revision: v3.5.0 was removed.
    Difference
    0.1%
    Check dated 2026-04-17T02:39:56.000Z thumbnail image
  7. Check
    99 days ago
    Change Detected
    Summary
    Revision history shows a new revision v3.5.0 added and an older revision v3.4.3 removed.
    Difference
    0.1%
    Check dated 2026-03-19T06:12:56.000Z thumbnail image

Stay in the know with updates to Ixazomib Role in ASCT in Relapsed Myeloma - Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ixazomib Role in ASCT in Relapsed Myeloma - Clinical Trial page.